Pacific Rim Cobalt Signs Preliminary Offtake Agreement With

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
232
Pacific Rim Cobalt Signs Preliminary Offtake Agreement With China's Top Battery Materials Supplier, Beijing Easpring

VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- Pacific Rim Cobalt Corp. (CSE:BOLT) (FRANKFURT: NXFE ) (OTCQB:PCRCF) (the “Company” or “Pacific Rim Cobalt”) a resource company currently exploring the Cyclops Nickel-Cobalt Project ("Cyclops"), located proximal to the world’s largest cobalt market, is pleased to announce that it has entered into a non-binding Preliminary Offtake Agreement (the "Agreement") with Beijing Easpring Material Technology Co., Ltd. ("Easpring"). Easpring and the Company intend to formalize the terms of a definitive binding agreement (the “Definitive Agreement”) subject to further due diligence to be completed between the parties.

The Definitive Agreement is expected to grant Easpring the right to purchase nickel sulphate and cobalt sulphate (the “Products”) from the Company’s Cyclops project for an initial term of 5 years from the commencement of commercial production. Annual volume will be determined in the Definitive Agreement, and it is presently intended that the Company will not be limited in respect of third parties to which it may sell any amount of Product not committed to Easpring. Pricing is intended to be linked directly to LME and LMB quoted metal pricing for nickel and cobalt respectively, with sulphate premia to be agreed quarterly based on the prevailing market pricing. Specific pricing parameters will be determined with greater certainty in the Definitive Agreement.

In addition, the Agreement contemplates a Strategic Investment Option, providing Easpring a preferential opportunity to make an equity investment directly in Pacific Rim Cobalt, or invest at the project level in Cyclops or other nickel-cobalt assets acquired by the Company.

Jashon Guan, Purchasing Director of Easpring stated, “The demand for lithium ion batteries is growing rapidly due to the global shift to electric vehicle usage. Our partnership with Pacific Rim Cobalt is an important part of Beijing Easpring’s strategy.” 

Ranjeet Sundher, President of Pacific Rim Cobalt commented “The signing of this agreement exemplifies the commitment of our company to China which we see as the future global centre for battery production. We are eager to fully explore the potential of the Cyclops project as well as other projects under review with Easpring.”

Founded in 2001 and based in Beijing, China, Easpring engages in the research, development, production and sale of energy materials. It offers lithium cobalt oxide, multi-element oxide, lithium manganese oxide, and other cathode materials for small lithium batteries and power batteries, as well as electronic ceramics materials. The company is a leading specialized supplier of cathode material for lithium-ion batteries to industry giants such as Samsung, Sony, Panasonic, SK Continental and BYD.

Today, Easpring is recognized as the leader in China in its industry and was one of the first Chinese suppliers to export lithium cathode material to multiple overseas markets. Presently, Easpring supplies five of the world's six largest lithium battery manufacturers, and is one of the only Chinese suppliers that simultaneously sells high quality cathode materials to China, Japan and Korea's high-end lithium ion battery markets.

Caution Regarding Cyclops Project Stage of Development

The Cyclops project is at an early stage of exploration. No resource estimate, Preliminary Economic Assessment (PEA), Pre-Feasibility Study (PFS) or Feasibility Study (FS) has been completed to demonstrate the technical feasibility and economic viability of the project at any level of confidence.  Nickel/cobalt laterite projects can be extremely capital intensive often with very complex metallurgical issues requiring significant capital investment. The Company does not currently possess the financial resources to complete the study(ies) to establish the technical feasibility of economic viability of the project or initiate construction should the technical feasibility of economic viability of the project be supported by a PEA, PFS and/or FS.  As a result the Company is not currently in a position to deliver the Products as expected pursuant to the initial terms of the Definitive Agreement without significant capital investment in the Company. Please refer to the risk factors set out in the Company’s CSE Form 2A Listing Statement dated October 19, 2017 and further details in respect of the Cyclops project in the Company’s current technical report dated December 8, 2017, each available at www.sedar.com.

Pacific Rim Cobalt Corporation:

Pacific Rim Cobalt Corp. is a Canadian publicly listed company currently focused on the development of cobalt projects within Indonesia. The Company believes cobalt will be the next dominant investment trend related to the critical components of lithium-ion batteries. Cobalt is currently in a global supply deficit, has a vulnerable supply chain, and is part of an emerging sector with extraordinary potential. For more information, visit:  www.pacificrimcobalt.com .

CONTACT Pacific Rim Cobalt Corp. Ranjeet Sundher – President and CEO (604) 922-8272 rsundher@pacificrimcobalt.com   Steve Vanry – CFO & Director (604) 922-8272 steve@vanrycap.com   Sean Bromley – Director & Investor Contact (778) 985-8934 sean@theparmargroup.com

Notice Regarding Forward-Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in both Pacific Rim Cobalt’s periodic filings with Canadian securities regulators. When used in this news release, words such as "will", "plan", "estimate", "expect", "intend", "potential", "should," and similar expressions, are forward-looking statements. Information provided in this document is necessarily summarized and may not contain all available material information. Forward-looking statements include, without limitation, statements regarding the progress of a definitive offtake agreement, potential development and production at the Company’s Cyclops project, future oriented events and other statements that are not facts. Forward-looking statements are based on a number of assumptions and estimates that, while considered reasonable by management based on the business and markets in which Pacific Rim Cobalt operates, are inherently subject to significant operational, economic and competitive uncertainties and contingencies. Such forward-looking statements should therefore be construed in light of such factors. Although Pacific Rim Cobalt has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release, and Pacific Rim Cobalt disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Pacific Rim Cobalt does not assume any liability for disclosure relating to any other company herein.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore, Schulman & Moore Attorneys Earn Top Honors Again

Updated Category News Views 4

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Continue Reading
Ingram Mercantile's Aviation Push: SCORE or Sink?

Updated Category News Views 5

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
Armor Health Strengthens Corrections Care with New Leader

Updated Category News Views 4

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 5

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Updated Category News Views 4

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Continue Reading
STRATA Showcases Excimer Laser Success in Dermatology

Updated Category News Views 4

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Continue Reading
Navigating Career Growth Beyond Job Titles at Webinar

Updated Category News Views 5

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Continue Reading
Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 3

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading

Top 5 Most Recently Viewed Articles

Caribou Biosciences Faces Securities Fraud Lawsuit Amid Losses

Updated Category News Views 139

Understanding the Lawsuit Against Caribou Biosciences Investors in Caribou Biosciences, Inc. (NASDAQ: CRBU) are currently facing significant challenges due to alleged misleading statements made by the company regarding its performance and product safety. A shareholder has initiated a class action lawsuit aimed at representing those who purchased CRBU securities between...

Continue Reading
BMO's Belsky Predicts Resilience of US Stocks Amid Volatility

Updated Category News Views 496

BMO's Bullish Outlook on US Stocks Brian Belsky, the Chief Investment Strategist at BMO Capital Markets, continues to maintain a positive outlook on US equities, despite the recent fluctuations in the market. His unwavering confidence comes even as the S&P 500 experiences losses in four out of the last five weeks. Belsky highlights that this downturn has been largely...

Continue Reading
How Is Pain and Suffering Calculated in Personal Injury Cases?

Updated Category Personal Finance Views 36

Pain and suffering is generally calculated by considering how an injury affects a person's physical comfort, emotional well-being, daily activities, and overall quality of life. Unlike medical bills or lost wages, these losses do not have a fixed price, so courts and insurance companies look at the nature and severity of the injury, recovery period, and long-term effects...

Continue Reading
Leap Therapeutics Showcases Financial Progress and Updates

Updated Category News Views 262

Leap Therapeutics: Financial Highlights and Updates Leap Therapeutics, Inc. (NASDAQ: LPTX), a prominent biotechnology firm dedicated to developing innovative immuno-oncology solutions, has recently revealed its financial results for the latest fiscal year. The focus today is not just on their financial performance, but also on the progress of their in-development...

Continue Reading
Tech Stocks Struggle Amid Economic Growth Concerns

Updated Category News Views 47

Current Trends Impacting Tech Stocks US tech stocks are facing significant challenges, reflecting broader worries about economic growth and the unpredictable AI market. Notably, Nvidia's shares have seen a considerable drop, highlighting the potential impacts on the technology sector. As a leading player in AI technologies, Nvidia's substantial loss in market value...

Continue Reading